Regeneron Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…

Biotechnology
US, Tarrytown [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
Download
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2014 4.2300 9.720 2,104 2,777 424 341 760 849 760 822 329 498
2015 3.3600 12.666 2,819 4,186 348 628 838 1,281 838 1,219 504 847
2016 6.1700 11.614 4,103 4,928 636 826 1,251 1,360 1,251 1,255 838 1,117
2017 8.5500 15.679 4,860 5,788 895 1,046 1,330 1,978 1,330 1,822 1,177 1,162
2018 11.2700 21.679 5,872 6,516 1,198 2,053 2,079 2,313 2,079 2,143 1,320 1,311
2019 21.2900 24.205 6,710 7,819 2,444 2,080 2,534 2,630 2,534 2,171 1,556 1,794
2020 19.3800 30.326 7,863 8,497 2,115 2,988 2,209 3,490 2,209 3,054 1,834 1,152
2021 32.6500 71.520 8,497 15,696 3,513 7,291 3,867 8,792 3,576 8,027 1,346 1,533
2022 76.4000 42.600 16,071 11,862 8,075 4,489 9,383 5,291 8,946 5,450 1,824 1,552
2023 40.5100 42.621 12,172 12,939 4,338 3,953 5,173 5,820 4,994 5,995 2,115 1,707
2024 37.0500 44.710 13,117 14,138 3,953 5,083 5,130 6,039 4,233 5,665 2,631 2,487
2025 - 45.264 - 14,691 - 5,183 - 6,276 - 5,887 - 2,584
2026 - 2.F12X/td> - 2.F12X/td> - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 1.F13X/td> - 1.F13X/td> - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 0.F14X/td> - 0.F14X/td> - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
End of REGN's Analysis
CIK: 872589 CUSIP: 75886F107 ISIN: US75886F1075 LEI: - UEI: -
Secondary Listings
REGN has no secondary listings inside our databases.